Marbocare flavour 80mg tablets for dogs
Country: Spain
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
10-09-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
marbofloxacin 80 mg
Available from:
Emdoka bvba
ATC code:
QJ01MA
Pharmaceutical form:
Tablet
Therapeutic group:
Fluoroquinolones
Therapeutic area:
Dogs Non Food
Authorization date:
2013-06-26
Summary of Product characteristics
Issued: September 2013
AN: 00540/2012
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Marbocare flavour 80mg tablets for dogs (UK and IE)
Marbocare F 80mg tablets for dogs (FR)
Odimar 80mg tablets for dogs (BE, LU, NL)
Marbofloxacin WDT 80mg flavoured tablets for dogs (AT, DE)
Marbofloxacino Emdoka 80mg tablets for dogs (ES)
Marbofloxacina Emdoka 80mg tablets for dogs (PT)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
EACH TABLET CONTAINS:
ACTIVE SUBSTANCE:
Marbofloxacin 80.0mg
EXCIPIENTS:
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet
Beige brown spotted oblong tablets, deep score line upper side, score line lower side.
The tablet can be divided into halves.
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Marbofloxacin is indicated in the treatment of the following infections caused by
susceptible strains of organisms (See section 5.1);
Skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis,
furunculosis, cellulitis).
Urinary tract infections (UTI) associated or not with prostatitis or epididymitis.
Respiratory tract infections.
Issued: September 2013
AN: 00540/2012
Page 2 of 6
4.3 CONTRAINDICATIONS
Do not use in dogs aged less than 12 months, or less than 18 months for exceptionally
large breeds of dogs, such as Great Danes, Briard, Bernese, Bouvier and Mastiffs, with
a longer growth period.
Do not use in cats. For the treatment of this species, a 5 mg tablet is available.
Do not use in animals with known hyp
Read the complete document
